Your browser doesn't support javascript.
loading
ALARM NMR for HTS triage and chemical probe validation.
Dahlin, Jayme L; Cuellar, Matthew; Singh, Gurpreet; Nelson, Kathryn M; Strasser, Jessica; Rappe, Todd; Xia, Youlin; Veglia, Gianluigi; Walters, Michael A.
Affiliation
  • Dahlin JL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Cuellar M; Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
  • Singh G; Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
  • Nelson KM; Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
  • Strasser J; Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
  • Rappe T; Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
  • Xia Y; Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
  • Veglia G; Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
  • Walters MA; Institute for Therapeutics Discovery and Development, University of Minnesota, Minneapolis, MN, USA.
Curr Protoc Chem Biol ; 10(1): 91-117, 2018 03.
Article in En | MEDLINE | ID: mdl-30034947
ABSTRACT
Nonspecific target engagement by test compounds and purported chemical probes is a significant source of assay interference and promiscuous bioactivity in high-throughput screening (HTS) and chemical biology. Most counter-screens for thiol-reactive compounds utilize mass spectrometry or fluorescence detection, and non-proteinaceous reporters like glutathione that may not always approximate the reactivity of protein side-chains. By contrast, a La assay to detect reactive molecules by nuclear magnetic resonance (ALARM NMR) is an industry-developed protein-based [1H-13C]-heteronuclear multiple quantum coherence (HMQC) NMR counter-screen to identify nonspecific protein interactions by test compounds by reporting their tendencies to modulate the human La antigen conformation. This Current Protocol is a users-guide to the production of the 13C-labeled La antigen reporter protein, the reaction of test compounds with this reporter protein, as well as the collection and analysis of characteristic NMR spectra. Combined with other assay interference counter-screens, this assay will enhance chemical biology by helping researchers better prioritize chemical matter and which will increase the number of tractable HTS screening actives and aid in the development of better chemical probes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Molecular Probes / Proteins / Nuclear Magnetic Resonance, Biomolecular / High-Throughput Screening Assays Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Protoc Chem Biol Year: 2018 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Molecular Probes / Proteins / Nuclear Magnetic Resonance, Biomolecular / High-Throughput Screening Assays Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Protoc Chem Biol Year: 2018 Document type: Article Affiliation country: Estados Unidos